In this study, with the goal of elucidating the mechanistic role of AURKC in cancer cell transformation, we identified IκBα as a novel AURKC binding partner and an inhibitor capable of targeting the AURKC–IκBα interaction in breast cancer cells. Here, NFKBIA is linked to breast cancer.